Radiology devices will remain the most US FDA approved AI-driven medical devices, while cardiovascular devices continue to grow due to technological advancements and high demand.
The market is dominated by leading medical device manufacturers, which we expect to remain in the near term.
The FDA will continue to evaluate and update regulations to balance innovation with patient safety measures, which can delay market entry.